Susquehanna International Group’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
114,359
+49,471
| +76% | +$54.4K | ﹤0.01% | 5803 |
|
|
2025
Q1 | $63.6K | Sell |
64,888
-3,087
| -5% | -$3.03K | ﹤0.01% | 5972 |
|
|
2024
Q4 | $106K | Sell |
67,975
-17,843
| -21% | -$27.8K | ﹤0.01% | 5668 |
|
|
2024
Q3 | $315K | Sell |
85,818
-29,877
| -26% | -$110K | ﹤0.01% | 4235 |
|
|
2024
Q2 | $383K | Buy |
115,695
+46,244
| +67% | +$153K | ﹤0.01% | 3884 |
|
|
2024
Q1 | $296K | Buy |
69,451
+57,628
| +487% | +$245K | ﹤0.01% | 4186 |
|
|
2023
Q4 | $21.3K | Sell |
11,823
-20,730
| -64% | -$37.3K | ﹤0.01% | 5666 |
|
|
2023
Q3 | $64.8K | Sell |
32,553
-11,052
| -25% | -$22K | ﹤0.01% | 5049 |
|
|
2023
Q2 | $112K | Buy |
+43,605
| New | +$112K | ﹤0.01% | 4967 |
|
|
2022
Q3 | – | Sell |
-14,466
| Closed | -$34K | – | 6743 |
|
|
2022
Q2 | $34K | Buy |
+14,466
| New | +$34K | ﹤0.01% | 5324 |
|